Pharmacovigilance Regulation OpinionVastuvõetud arvamused on 28/03/2012Viide: INT/639-EESC-2012-812Referral: COM(2012) 51 final - 2012/0023 (COD) Täiskogu istungjärk: 479 - Mar 28, 2012 Mar 29, 2012 EMSK arvamus: Pharmacovigilance Regulationbg cs da de el en es et fi fr hu it lt lv mt nl pl pt ro sk sl sv
Pharmacovigilance Directive OpinionVastuvõetud arvamused on 28/03/2012Viide: INT/638-EESC-2012-811Referral: COM(2012) 52 final - 2012/0025 (COD) Täiskogu istungjärk: 479 - Mar 28, 2012 Mar 29, 2012 EMSK arvamus: Pharmacovigilance Directivebg cs da de el en es et fi fr hu it lt lv mt nl pl pt ro sk sl sv
Information to the general public /medicinal products for human use OpinionVastuvõetud arvamused on 28/03/2012Viide: INT/637-EESC-2012-810Referral: COM(2012) 49 final - 2008/0255 (COD) Täiskogu istungjärk: 479 - Mar 28, 2012 Mar 29, 2012 EMSK arvamus: Information to the general public /medicinal products for human usebg cs da de el en es et fi fr hu it lt lv mt nl pl pt ro sk sl sv
Information to the general public / Medicinal products subject to medical prescription OpinionVastuvõetud arvamused on 28/03/2012Viide: INT/636-EESC-2012-809Referral: COM(2012) 48 final - 2008/0256 (COD) Täiskogu istungjärk: 479 - Mar 28, 2012 Mar 29, 2012 EMSK arvamus: Information to the general public / Medicinal products subject to medical prescriptionbg cs da de el en es et fi fr hu it lt lv mt nl pl pt ro sk sl sv
Information to the general public on medicinal products – Directive OpinionVastuvõetud arvamused on 22/02/2012Viide: INT/602-EESC-2012-469Referral: COM(2011) 633 final - 2008/0256 (COD) Täiskogu istungjärk: 478 - Feb 22, 2012 Feb 23, 2012 EMSK arvamus: Information to the general public on medicinal products – Directivebg cs da de el en es et fi fr hu it lt lv mt nl pl pt ro sk sl sv
Information to the general public on medicinal products - Regulation OpinionVastuvõetud arvamused on 22/02/2012Viide: INT/601-EESC-2012-468Referral: COM(2011) 632 final - 2008/0255 (COD) Täiskogu istungjärk: 478 - Feb 22, 2012 Feb 23, 2012 EMSK arvamus: Information to the general public on medicinal products - Regulationbg cs da de el en es et fi fr hu it lt lv mt nl pl pt ro sk sl sv
Des médicaments sûrs et innovants OpinionVastuvõetud arvamused on 30/09/2009Viide: INT/478-EESC-2009-1456Referral: COM(2008) 666 final Rapporteur: M. Joost van Iersel (Employers - GR I / Netherlands) Täiskogu istungjärk: 456 - Sep 30, 2009 Oct 01, 2009 EMSK arvamus: Des médicaments sûrs et innovantsbg cs da de el en es et fi fr hu it lt lv mt nl pl pt ro sk sl sv
Telemedicine OpinionVastuvõetud arvamused on 15/07/2009Viide: TEN/378-EESC-2009-1197Referral: COM(2008) 689 final Rapporteur: Mr Lucien Bouis (Diversity Europe - GR III / France) Täiskogu istungjärk: 455 - Jul 15, 2009 Jul 16, 2009 Telemedicinebg cs da de el en es et fi fr hu it lt lv mt nl pl pt ro sk sl sv
Prevention of falsified medicinal products OpinionVastuvõetud arvamused on 15/07/2009Viide: INT/472-EESC-2009-1191Referral: COM(2008) 668 final - 2008/0261 (COD) Rapporteur: Mr Peter Morgan (Employers - GR I / United Kingdom) Täiskogu istungjärk: 455 - Jul 15, 2009 Jul 16, 2009 EMSK arvamus: Prevention of falsified medicinal productsbg cs da de el en es et fi fr hu it lt lv mt nl pl pt ro sk sl sv
Medicinal products for human use – Community code OpinionVastuvõetud arvamused on 10/06/2009Viide: INT/469-EESC-2009-1022Referral: COM(2008) 663 final - 2008/0256 (COD) Rapporteur: Ms Renate Heinisch (Diversity Europe - GR III / Germany) Täiskogu istungjärk: 454 - Jun 10, 2009 Jun 11, 2009 EMSK arvamus: Medicinal products for human use – Community codebg cs da de el en es et fi fr hu it lt lv mt nl pl pt ro sk sl sv